Registry on young women with breast cancer

Breast cancer in young women is complex. Various aspects are poorly understood. There is a need for a multi-centric registry to improve our understanding of aetiology, biology, treatment patterns and outcomes in young women with breast cancer (YWBC).

 Within this registry, retrospective data collection will be conducted for YWBC diagnosed from March 2018 onwards till December 2024. Simultaneously, prospective data gathering for new patients will be facilitated through a web-based software platform. To ensure ethical standards, informed consent will be diligently obtained from new or ongoing patients, granting permission for the retrieval of pertinent data from their medical records. The decision regarding the requirement for formal informed or data release consent, in accordance with institutional policies, will be made at individual centres subsequent to approval from their respective Ethics Committee, as applicable.

 Eligible participants who consent to participation will be assigned a unique identity number to uphold confidentiality. The entry of patient data into the designated registry will exclusively after obtaining informed consent. The registry will systematically accumulate comprehensive data encompassing demographics, pertinent medical history, administered treatments, occurrences of recurrence and disease progression, details of the last follow-up, and current clinical status from the medical records of YWBC.The clinical data collected is as mentioned in the Case record form. For patients who have undergone prior treatment, relevant data available in their medical records will be meticulously captured.